Citigroup Inc Adma Biologics, Inc. Put Options Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
Put Options
1 transactions
Others Institutions Holding ADMA
# of Institutions
395Shares Held
191MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21MShares$294 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$262 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$180 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$170 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$83 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.76B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...